Americans' use of trendy weight-loss drugs may allow the four largest US airlines to save up to $580 million a year in fuel According to the NYT, reducing the weight of passengers taking GLP-1 receptor agonist drugs, including Ozempi, will reduce fuel costs for American Airlines, Delta Air Lines, Southwest Airlines and United Airlines by 1.5% and increase earnings per share by 4% news. up to a maximum.